Switch View
© PR Newswire
03.10.2025
ISIN: US7665596034
Rigel Pharmaceuticals, Inc.
RIGL
LISTED
NASDAQ
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 3, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. Inducement Plan, approved by the Compensation Committee of Rigel's Board of Directors and granted as an inducement m...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor® Appoints Gregory T. Lucier to its Board of Directors
News Preview
Brings more than three decades of leadership experience in the life sciences industry
RADNOR, Pa., Oct. 3, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, toda...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present one poster and one oral presentation at the 2025 HAEi Regional Conference EMEA, taking place October 10-12, 2025 in Rome, Italy.
Dr. William Lumry, M.D., AR...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© BusinessWire
03.10.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 for the Treatment of Cognitive Impairment Associated with Schizophrenia
News Preview
Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ALTO-101 for the treatment of cognitive impairment associated with sc...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
03.10.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2025 Financial Results
News Preview
WARSAW, Ind., Oct. 3, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter earnings conference call will be webcast on Wednesday, November 5, 2025 at 8:30 a.m. ET. A news release detailing the quarterly results will be made available that day at 6:30 a.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
News Preview
SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans t...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US00166B1052
ALX Oncology Holdings Inc
ALXO
LISTED
NASDAQ
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced updated data from its Phase 2 ASPEN-06 (NCT05002127) trial...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
News Preview
NEEDHAM, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the Company will present insights from its enLIGHTEN™ Discovery Platform, and addi...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US19249H1032
Coherus Oncology Inc
CHRS
LISTED
NASDAQ
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
News Preview
– CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC’s upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 – – CHS-114, an anti-CCR8 cytolytic antibody, will also be featured in SITC’s upcoming webinar series “Targets for Cancer IO: A Deep Dive” on October 22, 2025 –...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US09077B1044
Bioatla Inc
BCAB
LISTED
NASDAQ
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
News Preview
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its proprietary CAB platform for the treatment of solid tumors, today announced that clinical data for its investigational AXL-target...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US95075A1079
Werewolf Therapeutics Inc
HOWL
LISTED
NASDAQ
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
News Preview
WATERTOWN, Mass., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions,...
Themefolio
Profiler
Peergroup
© Newsfile
03.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces Phase II Executive and Board Compensation Plan to Drive Long-Term Shareholder Value
News Preview
Toronto, Ontario--(Newsfile Corp. - October 3, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands, today announced the approval and adoption of its 2026-2031 Compensation Growth Plans, designed to retain and incentivize the executive team while alig...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
03.10.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted two newly-hired employees inducement options to purchase an aggregate of 30,000 shares of KalVista common stock on October 1, 2025 as inducements material to each employee entering into employment with KalVista. T...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: US1167941087
Bruker Corp
BRKR
LISTED
NASDAQ
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
News Preview
Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performanc...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.
News Preview
SUMTER, S.C., Oct. 3, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today will commemorate 55 years of manufacturing excellence at its Sumter, South Carolina facility, which throughout its history has been a core site within the Company's extensi...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US92854B1098
Vivani Medical, Inc.
VANI
LISTED
NASDAQ
Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off
News Preview
The Company expects to reestablish and announce a new record date as soon as possible The Company expects to reestablish and announce a new record date as soon as possible...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US29664W1053
Esperion Therapeutics Inc
ESPR
LISTED
NASDAQ
Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040
News Preview
ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories, Inc. and its affiliate Dr. Reddy’s Laboratories Ltd. (together, Dr. Reddy’s Laboratories). This agreement resolves the patent litigation brought by Esperion against Dr. Reddy’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US6951271005
Pacira Biosciences Inc
PCRX
LISTED
NASDAQ
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BRISBANE, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on October 2, 2025 to 15 new employees under Pacira’s Amended and Restated 2014 Inducement P...
Themefolio
Profiler
Peergroup
© Newsfile
03.10.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Announces Appointment of Dan Haroun to Its Board of Directors
News Preview
Toronto, Ontario--(Newsfile Corp. - October 3, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands is pleased to announce the appointment of Dan Haroun to its Board of Directors.Mr. Haroun brings more than 15 years of senior leadership experience in...
Themefolio
Profiler
Peergroup
© BusinessWire
03.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
News Preview
Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that it has published a presentation outlining why stockholders should vote on Broadwood’s GREEN Proxy Card “AGAINST” the propos...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US50127T1097
Kura Oncology Inc
KURA
LISTED
NASDAQ
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on October 1, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US6904691010
Ovid Therapeutics Inc
OVID
LISTED
NASDAQ
Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds
News Preview
Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up to $94 million in additional proceeds upon exercise of issued warrants Initial closing of approximately $81 million expected to fund current operating plan and clinical pipeline into 2028, with potential for up...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group 2025 third-quarter results webcast
News Preview
Straumann Holding AG
/ Key word(s): Quarter Results/Quarterly / Interim Statement
Invitation: Straumann Group 2025 third-quarter results webcast
03.10.2025 / 11:00 CET/CEST
Date: Wednesday, October 29, 2025
Time: 10:30 – 11:30 a.m. CET
Straumann Group will publish its 2025 third-quarter results on Wednesday, O......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.10.2025
ISIN: CH1175448666
Straumann Holding AG
STMN
LISTED
SIX
Straumann Group Webcast – Umsatzzahlen 3. Quartal 2025
News Preview
Straumann Holding AG
/ Schlagwort(e): Quartalsergebnis/Quartals-/Zwischenmitteilung
Einladung: Straumann Group Webcast – Umsatzzahlen 3. Quartal 2025
03.10.2025 / 11:00 CET/CEST
Datum: Mittwoch, 29. Oktober 2025Zeit: 10.30 – 11.30 Uhr MEZ
Die Straumann Group wird am Mittwoch, 29. Oktober 2025 gegen 07......
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US6904691010
Ovid Therapeutics Inc
OVID
LISTED
NASDAQ
Ovid announces positive topline results for the next-generation GABA-aminotransferase inhibitor, OV329, that demonstrate strong inhibitory activity and a potential best-in-category safety profile
News Preview
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant unmet need, today announced positive topline results from its Phase 1 healthy volunteer study evaluating the safety, tolerability, pharmacokinetic (PK...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: CA75704R1010
Red White & Bloom Brands Inc.
RWB
LISTED
CSE
Red White & Bloom Files 2025 Interim Financial Statements
News Preview
TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that it has completed and filed its interim financial statements for the periods ended March 31, 2025 and June 30, 2025, and the related management's discussion and analysis and CEO and CFO certificates. Copies of the noted d...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: US09058V1035
BioCryst Pharmaceuticals Inc
BCRX
LISTED
NASDAQ
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
RESEARCH TRIANGLE PARK, N.C., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted eight newly-hired employees stock options to purchase an aggregate of 115,000 shares, and restricted stock units (RSUs) covering an aggregate of 91,4...
Themefolio
Profiler
Peergroup
© Newsfile
03.10.2025
ISIN: CA57384M1077
Marvel Biosciences Corp.
MRVL
LISTED
TSX
Marvel Biosciences Announces Acceleration of Warrant Expiry Date
News Preview
Calgary, Alberta--(Newsfile Corp. - October 3, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is announcing that, further to the Company's press releases of May 16, 2024, June 21, 2024 and July 19, 2024, the Company is formally providing notice that...
Themefolio
Profiler
Peergroup
© EQS Newswire
03.10.2025
ISIN: CH0013841017
Lonza Group AG
LONN
LISTED
SIX
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member
News Preview
Lonza Group AG
/ Key word(s): Personnel
Lonza Nominates Claudia Süssmuth-Dyckerhoff as Board Member 03.10.2025 / 09:00 CET/CEST
Subject to her election at the AGM, Claudia will also be appointed Vice-Chair of the Board and a member of the Remuneration Committee
Jürgen Steinemann and Barbara Richmond will not stand for re-elec......
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR
News Preview
NEW YORK, Oct. 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR)....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development’s portfolio company Dilafor receives patent in the US for tafoxiparin in priming of labor
News Preview
STOCKHOLM, SWEDEN – October 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Dilafor has been granted a patent in the US protecting its drug candidate tafoxiparin for its main target indication, priming of labor. The patent will serve as a key asset as Dilafor advances into phase 3 clinical deve...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: FR0012127173
OSE Immunotherapeutics SA
OSE
LISTED
EURONEXT
Appointment of Marc Le Bozec as Interim CEO
News Preview
Appointment of Marc Le Bozec as Interim CEO...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
FDA approves Roche’s Tecentriq plus lurbinectedin as first-line maintenance therapy for extensive-stage small cell lung cancer
News Preview
Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) and Tecentriq Hybreza® (atezolizumab and hyaluronidase-tqjs) in combination with lurbinectedin (Zepzelca®) for the maintenance treatment of adult patients with extensive-stage small cell...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Change in the Roche Board of Directors
News Preview
Basel, 3 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Dr. Claudia Süssmuth Dyckerhoff has decided not to stand for re-election as a member of the Roche Board of Directors at the Annual General Meeting in 2026. Instead she will be nominated for election to the board of another company which is serving the healthcare industr...
Themefolio
Profiler
Peergroup
© PR Newswire
03.10.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
FDA Approves Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
News Preview
Combination reduced the risk of disease progression or death by 46% and risk of death by 27% in pivotal Phase 3 IMforte trial
Zepzelca and atezolizumab combination added to National Comprehensive Cancer Network® Guidelines for SCLC...
Themefolio
Profiler
Peergroup
© Newsfile
03.10.2025
ISIN: CA62858B1085
MyndTec Inc.
MYTC
LISTED
CSE
MyndTec Inc. Completes Fifth Tranche of Non-Brokered Private Placement
News Preview
Mississauga, Ontario--(Newsfile Corp. - October 2, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed the fifth tranche of its non-brokered private placement previously announced on January 30, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action Investigation - MLTX
News Preview
NEW YORK, Oct. 2, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
Nutex Health Inc. (NUTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 2, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US74587V1070
Puma Biotechnology Inc
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on October 1, 2025, the Compensation Committee of Puma’s Board of Directors approved the grant of an inducement restricted stock unit award covering 9,375 shares of Puma common stock to one new non-executive employee.
The award was granted under Puma’s 2017 Empl...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze
News Preview
– Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month – – Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month –...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Announces New Employee Inducement Grant Under NYSE Rule 303A.08
News Preview
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, today announced that on September 30, 2025, the Compensation Committee of its Board of Directors approved an equity inducement award to Jordan Thompson, the Company’s Vice President and Corporate Controller. The award was made in connection with Mr. Thomps...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Oct. 1, 2025, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock opti...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rosen Law Firm Encourages Encompass Health Corporation Investors to Inquire About Securities Class Action Investigation - EHC
News Preview
NEW YORK, Oct. 2, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behal...
Themefolio
Profiler
Peergroup
© Newsfile
02.10.2025
ISIN: CA75339A1012
Rapid Dose Therapeutics Corp.
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - October 2, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that as contemplated in the secured convertible notes (the "Notes") previously issued on its private placement financing (the "Financing"), and consistent with prior quarters, the Company intends to...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US81619Q1058
Select Medical Holdings Corp
SEM
LISTED
NYSE
Select Medical Holdings Corporation to Announce Third Quarter 2025 Results on Thursday, October 30, 2025
News Preview
MECHANICSBURG, Pa., Oct. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2025 on Thursday, October 30, 2025 after the market closes.
Select Medical will host a conference call r...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US04635X1028
Astria Therapeutics Inc
ATXS
LISTED
NASDAQ
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, granted stock options to purchase 173,000 shares of Astria’s common stock on October 1, 2025 under Astria’s 2022 Inducement Stock Incentive Plan. The 2022 Inducement Stock Incentive Plan is used...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2025 results after the financial markets close on Thursday, November 6, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to d...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US2074101013
Conmed Corp
CNMD
LISTED
NYSE
CONMED Corporation to Announce Third Quarter 2025 Financial Results on November 5, 2025
News Preview
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2025 after the market close on Wednesday, November 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here t...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Encore Presentations of Results From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2025
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced the acceptance of two abstracts for poster presentation and one abstract as an oral presentation at CHEST 2025 in Chicago, Illinois, October 19-22. The Company will also host a Learning Theatre titled “Advances...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US4364401012
Hologic Inc
HOLX
LISTED
NASDAQ
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
News Preview
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Interested participants may listen to the call by di...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US28036F1057
Edgewise Therapeutics Inc
EWTX
LISTED
NASDAQ
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
News Preview
BOULDER, Colo., Oct. 2, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc. ("Edgewise" or the "Company"), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on September 30, 2025, Edgewise gra...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that it has closed its previously announced underwritten public offering of 7,475,000 shares of its common stock, which includes 975,000 shares sold pursuant...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
ALT Deadline: ALT Investors with Losses in Excess of $50K Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qu...
Themefolio
Profiler
Peergroup
© PR Newswire
02.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors Have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 2, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) bet...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2025
ISIN: US68062P1066
Olema Pharmaceuticals, Inc.
OLMA
LISTED
NASDAQ
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics Appoints Brian Posner to its Board of Directors
News Preview
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the appointment of Brian Posner to its Board of Directors. Mr. Posner brings 35 years of executive, investm...
Themefolio
Profiler
Peergroup
© Globe Newswire
02.10.2025
ISIN: US87990A1060
Tenaya Therapeutics Inc
TNYA
LISTED
NASDAQ
Tenaya Therapeutics to Participate in Upcoming October Investor Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya’s Chief Executive Officer, will p...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
